Online Exclusives

Online Exclusives

Trump Administration Ends Fetal Tissue Research at NIH

In the latest in a string of decisions pleasing to anti-abortion groups, the Trump administration announced sharp cuts to federal spending on fetal-tissue research,...

Gene Modified in Chinese “CRISPR Babies” Associated with Premature Death

A new study in Nature Medicine indicates that the gene that He Jiankui, PhD, modified in twin baby girls to mitigate HIV risk in...

Insys Therapeutics to Pay $225 Million Settlement For Its Role in the Opioid Crisis

Drugmaker Insys Therapeutics has admitted to bribing physicians to prescribe fentanyl sublingual – its opioid painkiller – and will pay a $225 million settlement...

Health Care Worker Shortages Loom as Boomers Age and Policies Curtailing

According to a new study published in Health Affairs, immigrants (both citizens and non-citizens) make up a disproportionate share of workers caring for the...

Bluebird Bio Wins European Approval for First Beta Thalassemia Gene Therapy

Bluebird Bio’s one-time gene therapy, Zynteglo, has been cleared by EU regulators for the treatment of beta thalassemia in patients aged 12 and older....

FDA Launches Call Center for Compassionate Use Requests

The U.S. Food and Drug Administration (FDA) has launched a call center to field doctors’ requests for access to experimental cancer drugs for individual...

Prices Soar for U.S.’ Most Popular Drugs

A new study from JAMA Network Open indicated that prices for all but one of the best-selling brand name drugs in the U.S. increased...

India Sees Decline in Cases of Severe Anemia

India is home to one-quarter of patients with severe anemia, but a new report from the country’s Health Management Information System found that incidence...

Trump Administration Outlines New Drug Price Transparency Plans

As health-care costs emerges as a crucial issue in the 2020 presidential election, President Donald Trump is preparing to issue an executive order aimed...

Disparities in Time to Treatment Erased in the Affordable Care Act Era

In states that opted to expand Medicaid under the Affordable Care Act (ACA), the time to receiving cancer treatment was nearly identical among white...
Advertisement

Current Issue

June 2019, Volume 5, Issue 7

This issue features a debate about new treatment options for beta-thalassemia, a look at what’s driving skyrocketing drug prices in myeloma, and more.